Skip to main content
SpringerLink
Log in

Arterial Complications in Patients with Cancer

  • Chapter
  • First Online:
Cancer and Cardiovascular Disease

Abstract

Complications of peripheral arterial disease in cancer patients are associated with increased morbidity and mortality. Medical management with modification of vascular risk factors remains the first line of treatment for cancer patients with arterial occlusive disease. Endovascular or surgical revascularization is indicated for patients who have critical limb ischemia or disabling claudication symptoms. In this article, we review the management of peripheral arterial disease in cancer patients, and present a series of common and rare case examples of arterial complications that can occur during or after oncologic therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Levitan N, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore). 1999;78(5):285–91.

    Article  CAS  Google Scholar 

  2. Sorensen HT, et al. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343(25):1846–50.

    Article  CAS  PubMed  Google Scholar 

  3. Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol. 2005;6(6):401–10.

    Article  PubMed  Google Scholar 

  4. Herrmann J, et al. Vascular toxicities of cancer therapies: the old and the new--an evolving avenue. Circulation. 2016;133(13):1272–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Lenneman CG, Sawyer DB. Cardio-oncology: an update on cardiotoxicity of cancer-related treatment. Circ Res. 2016;118(6):1008–20.

    Article  CAS  PubMed  Google Scholar 

  6. Al-Kindi SG, Oliveira GH. Prevalence of preexisting cardiovascular disease in patients with different types of cancer: the unmet need for onco-cardiology. Mayo Clin Proc. 2016;91(1):81–3.

    Article  PubMed  Google Scholar 

  7. Di Nisio M, et al. Arterial thrombosis in ambulatory cancer patients treated with chemotherapy. Thromb Res. 2011;127(4):382–3.

    Article  CAS  PubMed  Google Scholar 

  8. Javid M, Magee TR, Galland RB. Arterial thrombosis associated with malignant disease. Eur J Vasc Endovasc Surg. 2008;35(1):84–7.

    Article  CAS  PubMed  Google Scholar 

  9. Bennett KM, et al. Outcomes of surgical revascularization for lower extremity arterial thromboembolism in patients with advanced malignancy. J Vasc Surg. 2014;60(4):987–92.

    Article  PubMed  Google Scholar 

  10. Morris-Stiff G, Lewis MH. Surgical treatment of acute limb ischaemia in the presence of malignancy. Int J Surg. 2010;8(3):233–5.

    Article  PubMed  Google Scholar 

  11. Tsang JS, et al. Acute limb ischemia in cancer patients: should we surgically intervene? Ann Vasc Surg. 2011;25(7):954–60.

    Article  PubMed  Google Scholar 

  12. Mouhayar E, et al. Outcome of acute limb ischemia in cancer patients. Vasc Med. 2014;19(2):112–7.

    Article  PubMed  Google Scholar 

  13. Allison MA, et al. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med. 2007;32(4):328–33.

    Article  PubMed  Google Scholar 

  14. Peripheral Arterial Disease (PAD) Fact Sheet. http://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_pad.htm. 2016. 06/16/2016 [cited 2016 9/05/2016].

  15. Hirsch AT, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317–24.

    Article  CAS  PubMed  Google Scholar 

  16. McDermott MM, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001;286(13):1599–606.

    Article  CAS  PubMed  Google Scholar 

  17. Diehm C, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation. 2009;120(21):2053–61.

    Article  PubMed  Google Scholar 

  18. Heart Protection Study Collaborative, G. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):7–22.

    Google Scholar 

  19. Poredos P, Jezovnik MK. Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease. Int Angiol. 2010;29(1):20–6.

    PubMed  CAS  Google Scholar 

  20. El Sakka K, et al. Association of malignant disease with critical leg ischaemia. Br J Surg. 2005;92(12):1498–501.

    Article  PubMed  Google Scholar 

  21. Norgren L, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–67.

    Article  Google Scholar 

  22. Fowkes FG, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–40.

    Article  Google Scholar 

  23. Fowler B, et al. Improving maximum walking distance in early peripheral arterial disease: randomised controlled trial. Aust J Physiother. 2002;48(4):269–75.

    Article  PubMed  Google Scholar 

  24. Hankey GJ, Norman PE, Eikelboom JW. Medical treatment of peripheral arterial disease. JAMA. 2006;295(5):547–53.

    Article  CAS  PubMed  Google Scholar 

  25. Rooke TW, et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;58(19):2020–45.

    Article  PubMed  Google Scholar 

  26. Klinkert P, et al. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg. 2003;37(1):149–55.

    Article  PubMed  Google Scholar 

  27. Indes JE, et al. Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis. J Endovasc Ther. 2013;20(4):443–55.

    Article  PubMed  Google Scholar 

  28. Conte MS, et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006;43(4):742–751; discussion 751.

    Google Scholar 

  29. Adam DJ, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366(9501):1925–34.

    Article  CAS  Google Scholar 

  30. Aggarwal V, Waldo SW, Armstrong EJ. Endovascular revascularization for aortoiliac atherosclerotic disease. Vasc Health Risk Manag. 2016;12:117–27.

    PubMed  PubMed Central  Google Scholar 

  31. Dake MD, et al. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther. 2011;18(5):613–23.

    Article  PubMed  Google Scholar 

  32. Tran K, et al. Real-world performance of paclitaxel drug-eluting bare metal stenting (Zilver PTX) for the treatment of femoropopliteal occlusive disease. Ann Vasc Surg. 2017;38:90–8.

    Article  PubMed  Google Scholar 

  33. Candy N, Ng E, Velu R. Paclitaxel-coated balloon reduces target lesion revascularization compared with standard balloon angioplasty. J Vasc Surg. 2017;65(2):558–70. e10

    Article  PubMed  Google Scholar 

  34. Laird JR, et al. Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA. J Am Coll Cardiol. 2015;66(21):2329–38.

    Article  PubMed  Google Scholar 

  35. Duda SH, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther. 2006;13(6):701–10.

    Article  PubMed  Google Scholar 

  36. Hajibandeh S, et al. Covered vs uncovered stents for aortoiliac and femoropopliteal arterial disease: a systematic review and meta-analysis. J Endovasc Ther. 2016;23(3):442–52.

    Article  PubMed  Google Scholar 

  37. Mwipatayi BP, et al. Durability of the balloon-expandable covered versus bare-metal stents in the Covered versus Balloon Expandable Stent Trial (COBEST) for the treatment of aortoiliac occlusive disease. J Vasc Surg. 2016;64(1):83–94. e1

    Article  PubMed  Google Scholar 

  38. McQuade K, et al., Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg. 2010;52(3):584–90; discussion 590–1, 591 e1–591 e7.

    Article  Google Scholar 

  39. Geraghty PJ, et al. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg. 2013;58(2):386–95. e4

    Article  PubMed  Google Scholar 

  40. Modrall JG, Sadjadi J. Early and late presentations of radiation arteritis. Semin Vasc Surg. 2003;16(3):209–14.

    Article  PubMed  Google Scholar 

  41. Baerlocher MO, et al. Primary stenting of bilateral radiation-induced external iliac stenoses. J Vasc Surg. 2004;40(5):1028–31.

    Article  PubMed  Google Scholar 

  42. Moutardier V, et al. Iliac atherosclerotic occlusive disease complicating radiation therapy for cervix cancer: a case series. Gynecol Oncol. 2002;84(3):456–9.

    Article  CAS  PubMed  Google Scholar 

  43. Haddad TC, Greeno EW. Chemotherapy-induced thrombosis. Thromb Res. 2006;118(5):555–68.

    Article  CAS  PubMed  Google Scholar 

  44. Fernandes DD, et al. Acute aortic thrombosis in patients receiving cisplatin-based chemotherapy. Curr Oncol. 2011;18(2):e97–100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Schutz FA, et al. Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes. Ann Oncol. 2011;22(6):1404–12.

    Article  CAS  PubMed  Google Scholar 

  46. Alhawiti N, et al. The tyrosine kinase inhibitor, nilotinib potentiates a prothrombotic state. Thromb Res. 2016;145:54–64.

    Article  CAS  PubMed  Google Scholar 

  47. Lang K, et al. Mortality and vascular events among elderly patients with chronic myeloid leukemia: a retrospective analysis of linked SEER-Medicare Data. Clin Lymphoma Myeloma Leuk. 2016;16(5):275–285.e1.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thoracic and Cardiovascular Surgery, The University of Texas – MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1489, Houston, TX, 77030-4009, USA

    Tam T. T. Huynh M.D. & Hue T. Cao M.P.A.S.

  2. Department of Interventional Radiology, The University of Texas – MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1489, Houston, TX, 77030-4009, USA

    Tam T. T. Huynh M.D.

  3. Thoracic and Orthopedic Center, The University of Texas – MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1489, Houston, TX, 77030-4009, USA

    Susana G. Palma R.N. & Karen C. Broadbent B.S.N., R.N, R.V.T.

Authors
  1. Tam T. T. Huynh M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hue T. Cao M.P.A.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susana G. Palma R.N.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Karen C. Broadbent B.S.N., R.N, R.V.T.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tam T. T. Huynh M.D. .

Editor information

Editors and Affiliations

  1. Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Syed Wamique Yusuf

  2. Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Jose Banchs

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Cite this chapter

Huynh, T.T.T., Cao, H.T., Palma, S.G., Broadbent, K.C. (2018). Arterial Complications in Patients with Cancer. In: Yusuf, S., Banchs, J. (eds) Cancer and Cardiovascular Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-62088-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-62088-6_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-62086-2

  • Online ISBN: 978-3-319-62088-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation